Changwu Xu

999 total citations
33 papers, 758 citations indexed

About

Changwu Xu is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Clinical Biochemistry. According to data from OpenAlex, Changwu Xu has authored 33 papers receiving a total of 758 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Cardiology and Cardiovascular Medicine and 7 papers in Clinical Biochemistry. Recurrent topics in Changwu Xu's work include Advanced Glycation End Products research (7 papers), Atrial Fibrillation Management and Outcomes (4 papers) and Cardiac Ischemia and Reperfusion (4 papers). Changwu Xu is often cited by papers focused on Advanced Glycation End Products research (7 papers), Atrial Fibrillation Management and Outcomes (4 papers) and Cardiac Ischemia and Reperfusion (4 papers). Changwu Xu collaborates with scholars based in China, Japan and Hong Kong. Changwu Xu's co-authors include Xiaorong Hu, Hong Jiang, Zhibing Lu, Xiaoya Zhou, Bo Cui, Jing Zhang, Jian Yang, Jing Chen, Qi Hu and Hong Jiang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Changwu Xu

33 papers receiving 749 citations

Peers

Countries citing papers authored by Changwu Xu

Since Specialization

Citations

This map shows the geographic impact of Changwu Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changwu Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changwu Xu more than expected).

Fields of papers citing papers by Changwu Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changwu Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changwu Xu. The network helps show where Changwu Xu may publish in the future.

Co-authorship network of co-authors of Changwu Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Changwu Xu. A scholar is included among the top collaborators of Changwu Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changwu Xu. Changwu Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	TCT-934 Early Administration of Heparin at First Medical Contact Versus in the Cath Lab for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention (HELP-PCI): A Multicenter, Randomized Trial 2024 ·Journal of the American College of Cardiology ·Jing Chen, Changwu Xu, (unknown), Bin Li, Wei Yao, Hui Wu, (unknown), Shuo Yang, (unknown), Jianfang Liu, Menglong Wang, Jian Yang, Hong Jiang	1
2	Angio-Based Coronary Functional Assessment Predicts 30-Day New-Onset Heart Failure After Acute Myocardial Infarction 2023 ·ESC Heart Failure ·(unknown), Hui Wu, Wenjie Zhou, Jing Zhang, Xing Jin, Changwu Xu, Bing Huang, Jian Yang, Hong Jiang, Jing Chen	8
3	Inhibition of Sema4D attenuates pressure overload-induced pathological myocardial hypertrophy via the MAPK/NF-κB/NLRP3 pathways 2023 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·(unknown), Cheng Xu, Changwu Xu, (unknown), (unknown), Ming O. Li, (unknown), Hao Xia, Zhongyuan Xia, (unknown)	6
4	Downregulation of P300/CBP-Associated Factor Attenuates Myocardial Ischemia-Reperfusion Injury Via Inhibiting Autophagy 2020 ·International Journal of Medical Sciences ·(unknown), Changwu Xu, Hao Xia, Jing Chen, Huafen Liu, Hong Jiang	17
5	Metformin decreased myocardial fibrosis and apoptosis in hyperhomocysteinemia -induced cardiac hypertrophy 2020 ·Current Research in Translational Medicine ·(unknown), Wei Song, Jingqiu Huang, Dong Wang, Changwu Xu	21
6	Downregulation of the transcriptional co-activator PCAF inhibits the proliferation and migration of vascular smooth muscle cells and attenuates NF-κB-mediated inflammatory responses 2019 ·Biochemical and Biophysical Research Communications ·(unknown), Changwu Xu, Jing Chen, Qi Li, Hong Jiang	12
7	Suv39h1 downregulation inhibits neointimal hyperplasia after vascular injury 2019 ·Atherosclerosis ·Jing Zhang, Jing Chen, Jun Yang, Changwu Xu, Qi Hu, Hui Wu, (unknown), Qing Guo, Wenqi Gao, (unknown), Chaojun Yang, Jian Yang	14
8	Down‐regulation of Suv39h1 attenuates neointima formation after carotid artery injury in diabetic rats 2019 ·Journal of Cellular and Molecular Medicine ·Jing Zhang, Jian Yang, Changwu Xu, Qi Hu, Jun Hu, Jing Chen, (unknown)	4
9	Cantharidin Attenuates the Proliferation and Migration of Vascular Smooth Muscle Cells through Suppressing Inflammatory Response 2018 ·Biological and Pharmaceutical Bulletin ·(unknown), Changwu Xu, Hong Jiang, Wenjing Li, (unknown), Hao Xia	20
10	Histone demethylase KDM3a, a novel regulator of vascular smooth muscle cells, controls vascular neointimal hyperplasia in diabetic rats 2016 ·Atherosclerosis ·Jing Chen, Jing Zhang, Jian Yang, Lin Xu, Qi Hu, Changwu Xu, Shuo Yang, (unknown)	37
11	IOX1, a JMJD2A inhibitor, suppresses the proliferation and migration of vascular smooth muscle cells induced by angiotensin II by regulating the expression of cell cycle-related proteins 2015 ·International Journal of Molecular Medicine ·Qi Hu, Jing Chen, Jing Zhang, Changwu Xu, Shuo Yang, (unknown)	22
12	Anti-inflammatory effect of sodium butyrate preconditioning during myocardial ischemia/reperfusion 2014 ·Experimental and Therapeutic Medicine ·Xiaorong Hu, Kai Zhang, Changwu Xu, (unknown), Hong Jiang	49
13	Resveratrol Attenuates Oxidative Stress Induced by Balloon Injury in the Rat Carotid Artery Through Actions on the ERK1/2 and NF-Kappa B Pathway 2013 ·Cellular Physiology and Biochemistry ·Jing Zhang, Jing Chen, Jian Yang, Changwu Xu, (unknown), Jiawang Ding, Hong Jiang	51
14	Resveratrol Inhibits Phenotypic Switching of Neointimal Vascular Smooth Muscle Cells After Balloon Injury Through Blockade of Notch Pathway 2013 ·Journal of Cardiovascular Pharmacology ·Jing Zhang, Jing Chen, Changwu Xu, Jian Yang, Qing Guo, Qi Hu, Hong Jiang	16
15	Inhibition of neointimal hyperplasia in the rat carotid artery injury model by a HMGB1 inhibitor 2012 ·Atherosclerosis ·Jing Chen, Jing Zhang, Lin Xu, Changwu Xu, Sisi Chen, Jian Yang, (unknown)	47
16	Effect of oestrogen replacement therapy on idiopathic outflow tract ventricular arrhythmias in postmenopausal women 2011 ·Archives of cardiovascular diseases ·Xiaorong Hu, Jichun Wang, Changwu Xu, Bo He, Zhibing Lu, Hong Jiang	13
17	Minocycline attenuates ischemia-induced ventricular arrhythmias in rats 2011 ·European Journal of Pharmacology ·Xiaorong Hu, Bing Wu, Xin Wang, Changwu Xu, Bo He, Bo Cui, Zhibing Lu, Hong Jiang	14
18	Ethyl pyruvate reduces myocardial ischemia and reperfusion injury by inhibiting high mobility group box 1 protein in rats 2011 ·Molecular Biology Reports ·Xiaorong Hu, Bo Cui, Xiaoya Zhou, Changwu Xu, Zhibing Lu, Hong Jiang	41
19	Increased serum HMGB1 is related to the severity of coronary artery stenosis 2009 ·Clinica Chimica Acta ·Xiaorong Hu, Hong Jiang, (unknown), Xiaoya Zhou, Changwu Xu, Zhibing Lu, Bo Cui, (unknown)	59
20	Relationship between sex hormones and idiopathic outflow tract ventricular arrhythmias in adult male patients 2009 ·Translational research ·Xiaorong Hu, Hong Jiang, Changwu Xu, Xiaoya Zhou, Bo Cui, Zhibing Lu	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact